Search research articles

Search research articles

Related Experiment Videos

Mast cell numbers in diffuse scleroderma.

K Nishioka, Y Kobayashi, I Katayama

Archives of Dermatology

|February 1, 1987

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

What is the origin of macroscopic friction?

Science advances·2018

Same author

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

The British journal of dermatology·2018

Same author

Novel autoantibody against the β2-glycoprotein I/human leucocyte antigen-DR complex in patients with refractory cutaneous ulcers.

The British journal of dermatology·2017

Same author

Value of ultrasonography findings for nail psoriasis before and after adalimumab administration.

Clinical and experimental dermatology·2017

Same author

Anti-RNA polymerase III antibody positive limited cutaneous systemic sclerosis with cryoglobulin-induced digital gangrene.

Clinical and experimental dermatology·2016

Same author

A gas circulation and purification system for gas-cell-based low-energy RI-beam production.

The Review of scientific instruments·2016

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mast cells, immune cells involved in inflammation, show dynamic changes in scleroderma skin. Their numbers fluctuate with disease progression, suggesting a role in the fibrotic process of scleroderma.

Area of Science:

Dermatology
Immunology
Pathology

Background:

Scleroderma is a chronic autoimmune disease characterized by fibrosis.
Mast cells are immune cells implicated in inflammatory and fibrotic processes.
Understanding mast cell dynamics in scleroderma is crucial for elucidating disease mechanisms.

Purpose of the Study:

To quantify mast cell numbers in the skin lesions of diffuse scleroderma and morphea.
To investigate the relationship between mast cell distribution and the stage of fibrosis in scleroderma.
To explore the potential role of mast cells in the fibrotic pathogenesis of scleroderma.

Main Methods:

Histological analysis of skin biopsies from patients with diffuse scleroderma and morphea.
Quantification of mast cells in the papillary and reticular dermis.

Related Experiment Videos

Grading of skin lesions based on collagen bundle morphology (grade 1-3).

Main Results:

In diffuse scleroderma, mast cells initially increased then decreased in the papillary dermis.
Mast cell numbers correlated with collagen bundle characteristics: increased with fine bundles (grade 2) and decreased with homogeneous bundles (grade 3).
Total cell counts varied by grade, while morphea showed reduced mast cells in grade 3 lesions.

Conclusions:

Mast cell populations undergo significant changes during the progression of scleroderma.
These dynamic changes suggest mast cells play a key role in the fibrotic development of scleroderma skin.
Further research into mast cell modulation could offer therapeutic targets for scleroderma.